BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16620633)

  • 1. [Development of drugs with antiherpetic activity].
    Lin JW; Chen QM; Zhou HM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jan; 41(1):60-2. PubMed ID: 16620633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicologic research on the antiherpetic preparation viracin and its effect on fetal development].
    Boiadzhieva N
    Akush Ginekol (Sofiia); 1988; 27(5):8-11. PubMed ID: 2851943
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between antiviral activity, oligonucleotide hybridisation and nucleic acids incorporation studies.
    Herdewijn P
    Antiviral Res; 2006 Sep; 71(2-3):317-21. PubMed ID: 16690140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds.
    Artemenko AG; Muratov EN; Kuz'min VE; Kovdienko NA; Hromov AI; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2007 Jul; 60(1):68-77. PubMed ID: 17550890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
    Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
    Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in antiherpetic drugs.
    Flowers FP; Araujo OE; Turner LA
    Int J Dermatol; 1988 Nov; 27(9):612-6. PubMed ID: 2852644
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinoic acid analogues inhibit human herpesvirus 8 replication.
    Caselli E; Galvan M; Santoni F; Alvarez S; de Lera AR; Ivanova D; Gronemeyer H; Caruso A; Guidoboni M; Cassai E; Dolcetti R; Di Luca D
    Antivir Ther; 2008; 13(2):199-209. PubMed ID: 18505171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on a substance with antiviral activity. XXI. Preparation and antiherpes activity of 2-acylamino-3,5-dichloropyridine].
    Garuti L; Ferranti A; Giovanninetti G; Baserga M; Mannini Palenzona A
    Farmaco Sci; 1981 Oct; 36(10):862-6. PubMed ID: 6273214
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on the development of drugs against smallpox.
    Tse-Dinh YC
    Curr Opin Investig Drugs; 2008 Aug; 9(8):865-70. PubMed ID: 18666034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on antiviral resistance.
    Griffiths PD
    J Clin Virol; 2009 Sep; 46(1):3-8. PubMed ID: 19615937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy.
    Schang LM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):953-6. PubMed ID: 17181411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral agents. Part 25: 2-(polysubstituted benzoylamino)-3,5-dichloro-pyridines with antiherpetic activity.
    Ferranti A; Roberti M; Garuti L; Giovanninetti G; Palenzona AM
    Pharmazie; 1988 May; 43(5):359-60. PubMed ID: 2845452
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
    Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
    Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design of drugs for HIV and HCV.
    De Clercq E
    Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of nucleoside-based antiviral drugs in ionic liquids.
    Kumar V; Malhotra SV
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5640-2. PubMed ID: 18796352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides as antivirals: dream or realistic perspective?
    Van Aerschot A
    Antiviral Res; 2006 Sep; 71(2-3):307-16. PubMed ID: 16621039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
    Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
    Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
    Schnute ME; Brideau RJ; Collier SA; Cudahy MM; Hopkins TA; Knechtel ML; Oien NL; Sackett RS; Scott A; Stephan ML; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3856-9. PubMed ID: 18595689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broccoli compound inhibits HSV.
    AIDS Patient Care STDS; 2003 Nov; 17(11):609. PubMed ID: 14748359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.